Modena Polyclinic Pioneers Rare Heart Procedure, Expanding Treatment Options for High-Risk Patients
Table of Contents
Innovative percutaneous mitral valvuloplasty offers new hope for elderly patients with severe mitral stenosis.
A Breakthrough in Cardiac Care
The modenese healthcare system continues to demonstrate its excellence with a groundbreaking procedure performed at the Policlinic of Modena. An 89-year-old patient, previously treated for aortic valve replacement, underwent a successful percutaneous mitral valvuloplasty, a minimally invasive technique to widen the mitral valve.This procedure offers a lifeline to patients deemed too high-risk for traditional open-heart surgery.
Addressing Severe Mitral Stenosis
Mitral stenosis, a narrowing of the mitral valve, restricts blood flow from the left atrium to the left ventricle. In severe cases, it can lead to heart failure and othre serious complications. The patient in this case suffered from severe organic mitral stenosis, making the percutaneous approach the only viable option.
A Rare and Complex procedure
This specific type of percutaneous mitral valvuloplasty, utilizing a dedicated Inoue balloon catheter, is exceptionally rare. Worldwide, only approximately one hundred such interventions are performed annually. the success of this procedure underscores the advanced capabilities of Modenese interventional cardiology.
The Inoue Technique: A Global Impact
The Inoue technique, developed in 1982 by Japanese cardiac surgeon Kanji Inoue, has primarily been utilized in Asia. Its submission at the Polyclinic of Modena signifies a broader adoption of this life-saving procedure. The technique involves using a specialized balloon catheter to dilate the narrowed mitral valve, improving blood flow.
This success opens new therapeutic perspectives for very elderly and fragile patients, thanks to the commitment and synergy of all the professional figures involved.
Dr. Fabio Sgura, Cardiovascular Team, Polyclinic of Modena
The Procedure and the Team
The procedure was meticulously executed by the cardiovascular team at the Polyclinic of Modena, under the guidance of Giuseppe Boriani. Key members included Fabio Sgura (hemodynamist), Salvatore Artti, Francesca Coppi (cardiac imaging expert), and Carlo Cappello (hospitalization lead), along with dedicated nursing staff, radiology technicians, and cardiology specialists.
Important Clinical Improvement
The intervention yielded remarkable results. The patient’s mitral stenosis improved from a severe condition (transvalvular gradient of 10 mmHg and valve area of 0.9 cm²) to a mild condition (2 mmHg and area of 2.1 cm²).This translates to a significant reduction in symptoms and improved quality of life for the patient.
Life After Mitral Valve Repair
Following mitral valve repair,patients often experience a return to normal activities,even including sports. however, medical professionals advise against pushing physical limits excessively. Regular check-ups and adherence to medical advice are crucial for long-term well-being.
Expanding Treatment Horizons
The success of this procedure marks a significant advancement for Modena interventional cardiology and offers hope for patients previously excluded from traditional cardiac surgery. It highlights the potential of minimally invasive techniques to address complex cardiac conditions in high-risk individuals.
The success obtained represents an vital step forward for Modena interventional cardiology. And for the care of patients who are excluded from cardiac surgery.
Dr. Fabio Sgura,cardiovascular Team,Polyclinic of Modena
